Profile: Med BioGene Inc. is a life science company. We focus on the development and delivery of genomic-based clinical laboratory diagnostic tests. Our Lungexpress Dx™ is a test for early stage non-small-cell lung cancer that analyzes the molecular profile of patient's tumor to provide information to assist in tailoring the treatment for that specific patient. This is the first & only gene expression based test for non-small-cell lung cancer shown to assist in determining patient's benefit from chemotherapy & prognosis for survival.